CRVO vs PH · $28.8M cap vs P/E 28, rev $21.50B
CervoMed Inc. (CRVO) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
CervoMed Inc. (CRVO) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported CRVO revenue for 2026-06-30 was $0. Net income was -$14.5M. CRVO currently screens at market cap $28.8M.
Latest reported PH revenue for 2026-06-30 was $21.50B. Net income was $3.65B. Revenue was up 8.3% from 2025-06-30 to 2026-06-30. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CRVO currently screens at market cap $28.8M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CRVO and PH stock pages for the full models.
Not investment advice.